Annual Revenue
$194.62 M
-$97.86 M-33.46%
31 December 2023
Summary:
Akebia Therapeutics annual revenue is currently $194.62 million, with the most recent change of -$97.86 million (-33.46%) on 31 December 2023. During the last 3 years, it has fallen by -$100.02 million (-33.95%). AKBA annual revenue is now -41.90% below its all-time high of $335.00 million, reached on 31 December 2019.AKBA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$37.43 M
-$6.22 M-14.25%
30 September 2024
Summary:
Akebia Therapeutics quarterly revenue is currently $37.43 million, with the most recent change of -$6.22 million (-14.25%) on 30 September 2024. Over the past year, it has dropped by -$4.62 million (-10.98%). AKBA quarterly revenue is now -70.38% below its all-time high of $126.36 million, reached on 30 June 2022.AKBA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$169.88 M
-$4.62 M-2.65%
30 September 2024
Summary:
Akebia Therapeutics TTM revenue is currently $169.88 million, with the most recent change of -$4.62 million (-2.65%) on 30 September 2024. Over the past year, it has dropped by -$24.33 million (-12.53%). AKBA TTM revenue is now -51.58% below its all-time high of $350.81 million, reached on 31 March 2020.AKBA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.5% | -11.0% | -12.5% |
| 3 y3 years | -34.0% | -23.2% | -19.1% |
| 5 y5 years | -6.3% | -59.3% | -47.8% |
AKBA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -34.0% | at low | -70.4% | +14.8% | -42.3% | at low |
| 5 y | 5 years | -41.9% | at low | -70.4% | +14.8% | -51.6% | at low |
| alltime | all time | -41.9% | >+9999.0% | -70.4% | +2338.3% | -51.6% | >+9999.0% |
Akebia Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $37.43 M(-14.3%) | $169.88 M(-2.6%) |
| June 2024 | - | $43.65 M(+33.9%) | $174.50 M(-6.8%) |
| Mar 2024 | - | $32.61 M(-42.0%) | $187.22 M(-3.8%) |
| Dec 2023 | $194.62 M(-33.5%) | $56.20 M(+33.7%) | $194.62 M(+0.2%) |
| Sept 2023 | - | $42.05 M(-25.4%) | $194.21 M(-3.3%) |
| June 2023 | - | $56.38 M(+40.9%) | $200.88 M(-25.8%) |
| Mar 2023 | - | $40.01 M(-28.3%) | $270.87 M(-7.4%) |
| Dec 2022 | $292.48 M(+38.2%) | $55.78 M(+14.5%) | $292.56 M(-0.6%) |
| Sept 2022 | - | $48.71 M(-61.4%) | $294.45 M(-0.0%) |
| June 2022 | - | $126.36 M(+104.8%) | $294.50 M(+33.2%) |
| Mar 2022 | - | $61.70 M(+7.0%) | $221.04 M(+4.4%) |
| Dec 2021 | $211.65 M(-28.2%) | $57.68 M(+18.3%) | $211.65 M(+0.8%) |
| Sept 2021 | - | $48.76 M(-7.9%) | $210.01 M(-5.1%) |
| June 2021 | - | $52.91 M(+1.2%) | $221.24 M(-14.4%) |
| Mar 2021 | - | $52.30 M(-6.7%) | $258.47 M(-12.3%) |
| Dec 2020 | $294.64 M | $56.04 M(-6.6%) | $294.64 M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $59.99 M(-33.5%) | $308.16 M(-9.4%) |
| June 2020 | - | $90.14 M(+1.9%) | $340.15 M(-3.0%) |
| Mar 2020 | - | $88.48 M(+27.2%) | $350.81 M(+4.7%) |
| Dec 2019 | $335.00 M(+61.3%) | $69.56 M(-24.4%) | $335.00 M(+3.0%) |
| Sept 2019 | - | $91.98 M(-8.8%) | $325.30 M(+13.5%) |
| June 2019 | - | $100.80 M(+38.7%) | $286.49 M(+22.2%) |
| Mar 2019 | - | $72.67 M(+21.4%) | $234.48 M(+12.9%) |
| Dec 2018 | $207.74 M(+14.6%) | $59.85 M(+12.6%) | $207.74 M(-12.9%) |
| Sept 2018 | - | $53.17 M(+9.0%) | $238.45 M(+5.2%) |
| June 2018 | - | $48.79 M(+6.2%) | $226.56 M(+9.8%) |
| Mar 2018 | - | $45.93 M(-49.3%) | $206.29 M(+13.8%) |
| Dec 2017 | $181.23 M(>+9900.0%) | $90.56 M(+119.4%) | $181.23 M(+96.6%) |
| Sept 2017 | - | $41.28 M(+44.8%) | $92.20 M(+81.1%) |
| June 2017 | - | $28.52 M(+36.7%) | $50.92 M(+127.3%) |
| Mar 2017 | - | $20.86 M(+1259.3%) | $22.40 M(+1359.3%) |
| Dec 2016 | $1.53 M | $1.53 M | $1.53 M |
FAQ
- What is Akebia Therapeutics annual revenue?
- What is the all time high annual revenue for Akebia Therapeutics?
- What is Akebia Therapeutics annual revenue year-on-year change?
- What is Akebia Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly revenue year-on-year change?
- What is Akebia Therapeutics TTM revenue?
- What is the all time high TTM revenue for Akebia Therapeutics?
- What is Akebia Therapeutics TTM revenue year-on-year change?
What is Akebia Therapeutics annual revenue?
The current annual revenue of AKBA is $194.62 M
What is the all time high annual revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high annual revenue is $335.00 M
What is Akebia Therapeutics annual revenue year-on-year change?
Over the past year, AKBA annual revenue has changed by -$97.86 M (-33.46%)
What is Akebia Therapeutics quarterly revenue?
The current quarterly revenue of AKBA is $37.43 M
What is the all time high quarterly revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly revenue is $126.36 M
What is Akebia Therapeutics quarterly revenue year-on-year change?
Over the past year, AKBA quarterly revenue has changed by -$4.62 M (-10.98%)
What is Akebia Therapeutics TTM revenue?
The current TTM revenue of AKBA is $169.88 M
What is the all time high TTM revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM revenue is $350.81 M
What is Akebia Therapeutics TTM revenue year-on-year change?
Over the past year, AKBA TTM revenue has changed by -$24.33 M (-12.53%)